# US Food and Drug Administration Competitive Generic Therapy Approvals and Drug Competition

**Authors:** Kevin Kho, Rinku Patel, Harinder Singh Chahal

PMC · DOI: 10.1001/jamainternmed.2025.6072 · JAMA Internal Medicine · 2025-11-17

## TL;DR

This study analyzes how pricing and sales volumes change for generic drugs after they receive approval from the FDA.

## Contribution

The study provides new insights into the relationship between FDA approvals and market competition for generic drugs.

## Key findings

- FDA approvals are associated with increased market competition for generic drugs.
- Drug pricing and sales volumes show significant variation following FDA approvals.

## Abstract

This cross-sectional study examines the dynamics of competitive generic therapy drug pricing and volume.

## Full-text entities

- **Chemicals:** CGT (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12624475/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12624475/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC12624475/full.md

---
Source: https://tomesphere.com/paper/PMC12624475